DEMONSTRATION WEBSITE: This site is for demonstration, web development, and research purposes only. This site is under development and in no way, shape, or form is an offer, solicitation, or representation of any service. This is a demo website.

About Royal Ponciana MedTech

Pioneering the Future of Healthcare Innovation

Headquartered in San Juan, Puerto Rico, leveraging Act 60 tax incentives to build a global export service in AI-enhanced telemedicine.

Executive Summary

Royal Ponciana MedTech, headquartered in San Juan, Puerto Rico, leverages Act 60 tax incentives to build a global export service in AI-enhanced telemedicine. We are executing a strategic roll-up of healthcare entities via a Solana-based equity token raise, targeting a $1B post-money valuation.

The surviving entity will convert tokens 1:1 into common LP units yielding 8% quarterly from VA and NAHS receivables. Our mission is to address nursing shortages in rural America, tribal hospitals, and the Veterans Administration by deploying advanced AI technology, blockchain credentialing, and wearable health monitoring devices.

Phase 1 secures 2,000 hospital beds with our integrated platform. Phase 2 expands globally to underserved markets. Our revenue model includes subscription services, per-bed fees, and healthcare data analytics sales, with projected Year-1 revenue of $180M run-rate.

This is not a solicitation or offer to buy/sell securities. All investments involve risk and are subject to regulatory approval.

Our Core Values

Guided by a commitment to innovation, accessibility, and sustainable impact in healthcare delivery.

Mission

Export AI telemedicine from Puerto Rico to relieve U.S. government capital pressures on VA and NAHS while scaling globally to underserved healthcare markets.

Vision

Transform healthcare delivery through AI-powered virtual nursing, making quality care accessible to rural communities, veterans, and tribal hospitals worldwide.

Innovation

Leverage cutting-edge AI, edge computing, and blockchain technology to create scalable, secure, and efficient healthcare solutions.

Impact

Address critical nursing shortages and healthcare gaps while delivering sustainable, tax-advantaged returns to our investors.

Meet Our Leadership Team

Experienced professionals and strategic investors committed to transforming healthcare delivery.

Diena

Diena

Co-Founder & Equity Partner

Healthcare operations and strategic growth

Mark Rubin

Mark Rubin

Co-Founder & Equity Partner

Finance and blockchain integrations for medtech

Bennett Wight Family Office

Bennett Wight Family Office

Family Office Representative

Investment strategy and rural healthcare advocacy

Global Movement Holdings

Global Movement Holdings

Lead Equity Holders

Consortium of global investors driving sustainable medtech innovation

Our Products & Services

Crimson Agent AI

Advanced predictive nursing AI system providing real-time patient monitoring, early warning detection, and clinical decision support for healthcare professionals.

Royal Bridge Wearables

Medical-grade wearable devices continuously monitoring vital signs and transmitting data to our AI platform for comprehensive patient health tracking.

Ponciana Credentials

Blockchain-based credential verification system for doctors and nurses, ensuring transparent, immutable, and instantly verifiable professional qualifications.

Market Strategy & Expansion

Primary Markets

Target rural U.S. healthcare facilities including Veterans Administration hospitals, Native American Health Service facilities, and HRSA-designated rural hospitals. Leverage inherited contracts from strategic acquisitions to accelerate market penetration.

Global Expansion

Phase 2 expansion targets underserved healthcare markets in Mexico, Europe, and Asia, bringing our AI-powered telemedicine platform to regions with critical healthcare access challenges.

Operations Hub

San Juan headquarters with solar-powered data centers, leveraging Puerto Rico's Act 60 tax incentives and strategic location for serving both U.S. and international markets.